Mednet Logo

Would you treat unfavorable intermediate risk prostate cancer in the setting of recently resected NSCLC?

How would a much higher risk cancer affect decision making? How would you treat him?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Case Western Reserve University/ University Hospitals Seidman Cancer Center
Answered on

This greatly depends on the stage of the lung cancer. If stage IIIA resected NSCLC, I would not treat the prostate cancer immediately, and effectively enter them into active surveillance until the patient is 2 years free of NSCLC on follow-up imaging. If they recur from NSCLC within 2 years, they ha...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center
Answered on

I agree with @Dr. First Last. The lung cancer represents the greater threat to the patient's life expectancy. I'll generally try to wait 2 years, as most lung cancer recurrences will occur within that time frame. Even stage 1 has a higher 5-year cancer-related mortality than does intermediate risk p...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

If lung cancer is being treated with a curative goal, then yes, I would treat prostate cancer also.

Join for free or sign in to see the full answer